Chaoyang, Liaoning, China The company was established in Asia in China. The main office of represented VC is situated in the Chaoyang.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Robotics, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Hexaell Biotech.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Shunwei Capital, ShenZhen GTJA Investment Group.
Related Funds
| Fund Name | Location |
| Arts Et Bien | France, Ile-de-France, Paris |
| Athenahealth | Massachusetts, United States, Watertown |
| Dembach Goo Informatik GmbH & Co. KG | Cologne, Germany, Nordrhein-Westfalen |
| Egora Holding | Bayern, Germany, Martinsried |
| Genesis Ark | China, Ningbo, Zhejiang |
| Lighthouse Capital Management | China, Shanghai |
| SWAT Equity Partners | New York, New York, United States |
| Technology Venture Corporation | Canada, New Brunswick, Ontario |
| US WEST Dex | Manhattan, New York, United States |
| Viking Fund | Normanton On Trent, Nottinghamshire, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Delova Biotech | $15M | 02 Apr 2024 | - | ||
Digital Precision Medical (DPM) | $30M | 22 Jan 2024 | Dongcheng District, Beijing, China | ||
Neomodulus | 07 Mar 2023 | Suzhou, Jiangsu, China | |||
Immunowake | $20M | 15 May 2022 | Birmingham, Alabama, United States | ||
Cargene | $19M | 14 Dec 2021 | Singapore, Central Region, Singapore | ||
Carcell Biopharma | $15M | 01 Nov 2021 | - | ||
Oculis | $57M | 04 May 2021 | Iceland, Iceland | ||
Elpiscience Biopharmaceuticals | $100M | 28 Dec 2019 | Shanghai, China | ||
| 26 Feb 2019 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Delova Biotech | $15M | 02 Apr 2024 | - | ||
Digital Precision Medical (DPM) | $30M | 22 Jan 2024 | Dongcheng District, Beijing, China | ||
Neomodulus | 07 Mar 2023 | Suzhou, Jiangsu, China | |||
Immunowake | $20M | 15 May 2022 | Birmingham, Alabama, United States | ||
Cargene | $19M | 14 Dec 2021 | Singapore, Central Region, Singapore | ||
Carcell Biopharma | $15M | 01 Nov 2021 | - | ||
Oculis | $57M | 04 May 2021 | Iceland, Iceland | ||
Elpiscience Biopharmaceuticals | $100M | 28 Dec 2019 | Shanghai, China | ||
| 26 Feb 2019 | China, Beijing |
